跳至主要内容
临床试验/IRCT20200827048539N1
IRCT20200827048539N1招募中3 期

Evaluation of the Effect of Zinc Prescription on Hemoglobin Level and Erythropoetin Dose Requirement in Hemodialysis Patients in comparison with Placebo

Esfahan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients who have been on hemodialysis for at least 3 months
  • More than 18 years of age
  • Consensus on participation in the study
  • Hemoglobin level less than 12 g/dl
  • Patients who are under ongoing therapy with injected erythropoetin
  • Not taking cholrthalidone, tetracycline and penicillin
  • Non pregnant and breastfeeding
  • On hemodialysis for at least twice a week
  • Not having cancer, acute inflammatory disease and severe hepatic failure

排除标准

  • Patients wanting to discontinue the cooperation for any reason
  • Discontinuing hemodialysis therapy
  • Surgical operation during the study
  • Blood transfusion during the study
  • Hemorrhage during the study
  • Development of malignant tumors during the study
  • Pregnancy during the study
  • Intolerance of drug
  • Non-compliance with the intervention (less than 70%)

研究者

相似试验